15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $2.7B | -$96M | 28.3% | -2.0% | $234M | $767M | $34M |
| 2024 | $3.0B | -$147M | 30.8% | -3.4% | $240M | $1.1B | $11M |
| 2023 | $3.8B | $211M | 33.0% | 8.9% | $268M | $1.3B | $33M |
| 2022 | $5.2B | $444M | 32.7% | 12.3% | $578M | $844M | $65M |
| 2021 | $4.0B | $327M | 32.9% | 12.0% | $252M | $842M | $181M |
| 2020 | $2.4B | $71M | 33.1% | 6.2% | $219M | $858M | $29M |
| 2019 | $2.2B | $114M | 33.5% | 8.0% | $190M | $617M | $83M |
| 2018 | $2.1B | $142M | 32.6% | 9.5% | $192M | $441M | $14M |
| 2017 | $2.0B | $133M | 32.4% | 10.7% | $134M | $320M | $15M |
| 2016 | $1.9B | $106M | 32.6% | 10.1% | $112M | $359M | $11M |
| 2015 | — | $82M | — | — | $29M | $181M | $10M |
| 2014 | — | $33M | — | — | $9M | $144M | $13M |
| 2013 | — | $33M | — | — | $51M | $150M | $16M |
| 2012 | — | $17M | — | — | $53M | $160M | $6M |
| 2011 | — | -$26M | — | — | $15M | $205M | $4M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $1.4B | $62M | 26.8% | 8.5% | $555M | — | $561M |
| Dec '25 | $748M | -$8M | 26.1% | 1.1% | $68M | $767M | $34M |
| Sep '25 | $634M | $29M | 29.1% | 7.5% | $15M | — | $53M |
| Jun '25 | $658M | -$116M | 29.8% | -18.8% | $69M | — | $42M |
| Mar '25 | $690M | -$1M | 28.7% | 1.8% | $83M | — | $56M |
| Dec '24 | $735M | -$188M | 29.8% | -27.6% | $57M | $1.1B | $11M |
| Sep '24 | $688M | $7M | 31.0% | 3.2% | $47M | — | $31M |
| Jun '24 | $741M | $16M | 31.0% | 5.1% | $72M | — | $48M |
| Mar '24 | $821M | $17M | 31.4% | 4.9% | $63M | — | $51M |
| Dec '23 | $818M | $12M | 31.9% | 4.2% | -$71M | $1.3B | $33M |
| Sep '23 | $853M | $53M | 33.9% | 10.2% | $142M | — | $29M |
| Jun '23 | $991M | $61M | 33.3% | 9.2% | $171M | — | $7M |
| Mar '23 | $1.1B | $84M | 32.8% | 11.2% | $26M | — | $29M |
| Dec '22 | $1.1B | $82M | 33.3% | 10.6% | $91M | $844M | $65M |
| Sep '22 | $1.1B | $92M | 33.8% | 12.0% | $93M | — | $156M |
| Jun '22 | $1.4B | $124M | 32.3% | 12.9% | $207M | — | $79M |
| Mar '22 | $1.6B | $146M | 32.0% | 13.4% | $187M | — | $113M |
| Dec '21 | $1.4B | $116M | 31.9% | 12.4% | $63M | $842M | $181M |
| Sep '21 | $878M | $74M | 34.8% | 12.1% | $1M | — | $137M |
| Jun '21 | $857M | $67M | 32.7% | 11.6% | $160M | — | $139M |
How the market has priced AMN against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Amn Healthcare Services Inc's revenue has grown 2.7% per year. These are computed facts, not advice.
As of FY2025, Amn Healthcare Services Inc reported $767M of total debt against $34M of cash; operating income covered interest expense -1.2×.
In FY2025, gross margin was 28.3%, operating margin -2.0%, and net margin -3.5%.
As of Jun '26, Amn Healthcare Services Inc traded at a price-to-earnings ratio of about 4.8× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.